» Articles » PMID: 27356902

The Evolutionary Histories of Antiretroviral Proteins SERINC3 and SERINC5 Do Not Support an Evolutionary Arms Race in Primates

Overview
Journal J Virol
Date 2016 Jul 1
PMID 27356902
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Molecular evolutionary arms races between viruses and their hosts are important drivers of adaptation. These Red Queen dynamics have been frequently observed in primate retroviruses and their antagonists, host restriction factor genes, such as APOBEC3F/G, TRIM5-α, SAMHD1, and BST-2. Host restriction factors have experienced some of the most intense and pervasive adaptive evolution documented in primates. Recently, two novel host factors, SERINC3 and SERINC5, were identified as the targets of HIV-1 Nef, a protein crucial for the optimal infectivity of virus particles. Here, we compared the evolutionary fingerprints of SERINC3 and SERINC5 to those of other primate restriction factors and to a set of other genes with diverse functions. SERINC genes evolved in a manner distinct from the canonical arms race dynamics seen in the other restriction factors. Despite their antiviral activity against HIV-1 and other retroviruses, SERINC3 and SERINC5 have a relatively uneventful evolutionary history in primates.

Importance: Restriction factors are host proteins that block viral infection and replication. Many viruses, like HIV-1 and related retroviruses, evolved accessory proteins to counteract these restriction factors. The importance of these interactions is evidenced by the intense adaptive selection pressures that dominate the evolutionary histories of both the host and viral genes involved in this so-called arms race. The dynamics of these arms races can point to mechanisms by which these viral infections can be prevented. Two human genes, SERINC3 and SERINC5, were recently identified as targets of an HIV-1 accessory protein important for viral infectivity. Unexpectedly, we found that these SERINC genes, unlike other host restriction factor genes, show no evidence of a recent evolutionary arms race with viral pathogens.

Citing Articles

Recognition and cleavage of human tRNA methyltransferase TRMT1 by the SARS-CoV-2 main protease.

DOliviera A, Dai X, Mottaghinia S, Olson S, Geissler E, Etienne L Elife. 2025; 12.

PMID: 39773525 PMC: 11706605. DOI: 10.7554/eLife.91168.


The host restriction factor SERINC5 inhibits HIV-1 transcription by negatively regulating NF-κB signaling.

Li W, Qu M, Zhang T, Li G, Wang R, Tian Y J Biol Chem. 2024; 301(1):108058.

PMID: 39653243 PMC: 11750542. DOI: 10.1016/j.jbc.2024.108058.


Beyond Impairment of Virion Infectivity: New Activities of the Anti-HIV Host Cell Factor SERINC5.

Sid Ahmed S, Bajak K, Fackler O Viruses. 2024; 16(2).

PMID: 38400059 PMC: 10892966. DOI: 10.3390/v16020284.


Mutations accumulated in the Spike of SARS-CoV-2 Omicron allow for more efficient counteraction of the restriction factor BST2/Tetherin.

Shi Y, Simpson S, Chen Y, Aull H, Benjamin J, Serra-Moreno R PLoS Pathog. 2024; 20(1):e1011912.

PMID: 38190411 PMC: 10798645. DOI: 10.1371/journal.ppat.1011912.


SERINC5: One antiviral factor to bind them all.

Timilsina U, Stavrou S PLoS Pathog. 2023; 19(1):e1011076.

PMID: 36656836 PMC: 9851522. DOI: 10.1371/journal.ppat.1011076.


References
1.
Murrell B, Moola S, Mabona A, Weighill T, Sheward D, Kosakovsky Pond S . FUBAR: a fast, unconstrained bayesian approximation for inferring selection. Mol Biol Evol. 2013; 30(5):1196-205. PMC: 3670733. DOI: 10.1093/molbev/mst030. View

2.
Evans D, Serra-Moreno R, Singh R, Guatelli J . BST-2/tetherin: a new component of the innate immune response to enveloped viruses. Trends Microbiol. 2010; 18(9):388-96. PMC: 2956607. DOI: 10.1016/j.tim.2010.06.010. View

3.
Sawyer S, Emerman M, Malik H . Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G. PLoS Biol. 2004; 2(9):E275. PMC: 479043. DOI: 10.1371/journal.pbio.0020275. View

4.
Sauter D, Schindler M, Specht A, Landford W, Munch J, Kim K . Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe. 2009; 6(5):409-21. PMC: 2779047. DOI: 10.1016/j.chom.2009.10.004. View

5.
Neil S, Zang T, Bieniasz P . Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature. 2008; 451(7177):425-30. DOI: 10.1038/nature06553. View